SkinVision Unveils Breakthrough Algorithm that Takes the Fight to Skin Cancer

Dutch mobile health startup SkinVision has revealed its new algorithm that can detect most common forms of deadly skin cancer. Previously focused on detecting melanoma skin cancer, the app can now identify Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) too, the first app ever to do that.

Across the world, more than one billion people are at risk of developing skin cancer at some point in their lives. Helping them prepare is a selected group of dermatologists. For example 10,000 in the US and only 550 in the UK. SkinVision’s new algorithm will help provide people with a means to assess moles for risk indication on demand to save time and lives. Users can download the app for free and can perform a number of free assessments as well.

There is a seamless connection between users and their doctors to monitor skin lesions with a personal archive that can be used as reference during visits, saving time and improving efficiency for dermatologists.

"Our mission is to empower people to early detect skin cancer, which is highly important for possible treatment options," says SkinVision founder and CEO Erik de Heus. "We aim to save 250,000 lives in the next decade."

Melanoma is a type of skin cancer that forms in the cells responsible for skin pigmentation, known as melanocytes. Although it is less common than other forms of skin cancer, it is much more aggressive. In the United States alone, melanoma accounts for more than, 10,000 of the 13,000 deaths caused by skin cancer each year. Research shows that 5,4 million non-melanoma skin cancer cases are identified every year in the US.

SkinVision has now expanded its remit to identify and alert people to these non-melanoma cancers, like BCC and SCC cancers, too.

"Our new algorithm can recognize nine in every 10 cases of deadly skin cancer," de Heus continues. "This is because our latest research shows 88 per cent sensitivity towards melanoma skin cancer. Our work has been scientifically tested in the leading dermatology clinic at Ludwig-Maximilians-Universitat Clinic in Munich, Germany."

SkinVision is available for both iPhone and Android (Samsung S4 and up only for now) here. The app can be used worldwide except in the US, although the company indicates it will be arriving there soon.

For further information, please visit:
http://skinvision.com

About SkinVision
SkinVision is a Dutch health startup based in Amsterdam. SkinVision's newest algorithm helps health conscious people to identify Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) skin cancers, as well as more aggressive melanoma varieties.

Most Popular Now

Accenture HealthTech Innovation Challeng…

Accenture (NYSE: ACN) has named eight companies as finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America's...

Researchers Use AI to Predict which COVI…

Researchers at Case Western Reserve University have developed an online tool to help medical staff quickly determine which COVID-19 patients will need help breathing with a ventilator. The tool, developed through...

Scientists Develop AI to Predict the Suc…

A study in which machine-learning models were trained to assess over 1 million companies has shown that artificial intelligence (AI) can accurately determine whether a startup firm will fail or...

Bittium Expands Its Minority Holdings in…

Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and British ECG service provider, Technomed Limited, have today signed an agreement under which Bittium will purchase a 25 percent stake in...

A Game Changer: Virtual Reality Reduces …

It isn’t a matter of one needle puncture. Many children coming through the doors of Children's Hospital Los Angeles are seen for chronic conditions and often require frequent visits. Painful...

Open Call HORIZON-HLTH-2022-IND-13-04: S…

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 "Maintaining an innovative, sustainable and globally competitive health industry". To...

Siemens Healthineers AI-based COVID-19 S…

Through a year-long collaboration with a number of leading healthcare institutions across the globe, Siemens Healthineers has developed the Atellica COVID-19 Severity Algorithm,(1) a model designed to help predict the...

Ranking Apps on Privacy

The last thing you want to do when installing a new, free app on your phone is to scroll through pages of information on what kind of access to your...

Almost Two Thirds of Thoracic Oncologist…

Nearly two-thirds of thoracic oncologists surveyed indicated they used telehealth tools for the first time during the COVID-19 pandemic, according to a report issued at the IASLC 2021 World Conference...

World First for AI and Machine Learning …

Addenbrooke's Hospital in Cambridge along with 20 other hospitals from across the world and healthcare technology leader, NVIDIA, have used artificial intelligence (AI) to predict COVID patients' oxygen needs on...

MEDICA 2021 + COMPAMED 2021: For the Res…

15 - 18 November 2021, Düsseldorf, Germany. The medical technology industry and its suppliers are looking forward to heading to the world's leading industry platforms, MEDICA 2021 and COMPAMED 2021, with...